Medtronic's current P/E and solid fundamentals make the stock more worthy of owning, says Oakmark manager Bill Nygren.
October data show continued inflows for bonds (including riskier fixed-income assets), while investors withdrew money from U.S. stock mutual funds and ETFs.
Morningstar's Christine Benz discusses current pockets of opportunity with director of ETF research Scott Burns, dividend strategist Josh Peters, and associate director of fixed-income fund analysis Miriam Sjoblom.
Morningstar's Jeremy Glaser and Christine Benz offer tips for assessing risk and opportunity in a tumultuous market.
©2012 Morningstar Advisor. All right reserved.